Dexamethasone in hyperleukocytic acute myeloid leukemia

Patients with acute myeloid leukemia and a high white blood cell count are at increased risk of early death and relapse. Because mediators of inflammation contribute to leukostasis and chemoresistance, dexamethasone added to chemotherapy could improve outcomes. This retrospective study evaluated the...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Haematologica
Главные авторы: Bertoli, Sarah, Picard, Muriel, Bérard, Emilie, Griessinger, Emmanuel, Larrue, Clément, Mouchel, Pierre Luc, Vergez, François, Tavitian, Suzanne, Yon, Edwige, Ruiz, Jean, Delabesse, Eric, Luquet, Isabelle, Linares, Laetitia Karine, Saland, Estelle, Carroll, Martin, Danet-Desnoyers, Gwenn, Sarry, Audrey, Huguet, Françoise, Sarry, Jean Emmanuel, Récher, Christian
Формат: Artigo
Язык:Inglês
Опубликовано: Ferrata Storti Foundation 2018
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6058767/
https://ncbi.nlm.nih.gov/pubmed/29519869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2017.184267
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы